Columnist Colleen Steele's son Cullen has endured PAH, a heart-lung transplant, and loss, but each trying situation has ...

The American Lung Association launched an awareness campaign to accelerate diagnosis and improve treatment of PAH.

Cereno Scientific has secured loan financing to continue developing CS1, its lead therapeutic candidate for pulmonary arterial hypertension.

Bionews, Inc., the parent company of this site, has partnered with the following nonprofit advocacy organizations to help further the mission of ensuring that patients and caregivers are able to get ...

Phaware Global Association ® is a 501(c)3 organization dedicated to raising global pulmonary hypertension awareness and creating innovative technology for PH research. Phaware® was co-founded by ...

Columnist Anna Jeter explains how reproductive healthcare was ingrained in both her PH treatment plan and her post-transplant ...

A Phase 2 clinical trial of TX45, Tectonic Therapeutic’s investigational therapy for pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), has begun enrolling eligible ...